Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Shares Outstanding (Weighted Average): 2022-2024

Historic Shares Outstanding (Weighted Average) for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $62.9 million.

  • Abivax's Shares Outstanding (Weighted Average) rose 0.78% to $63.4 million in Q2 2025 from the same period last year, while for Dec 2024 it was $62.9 million, marking a year-over-year increase of 0.10%. This contributed to the annual value of $62.9 million for FY2024, which is 0.10% up from last year.
  • As of FY2024, Abivax's Shares Outstanding (Weighted Average) stood at $62.9 million, which was up 0.10% from $62.9 million recorded in FY2023.
  • In the past 5 years, Abivax's Shares Outstanding (Weighted Average) registered a high of $62.9 million during FY2024, and its lowest value of $42.5 million during FY2022.
  • In the last 3 years, Abivax's Shares Outstanding (Weighted Average) had a median value of $62.9 million in 2023 and averaged $56.1 million.
  • Data for Abivax's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 47.77% (in 2023) over the last 5 years.
  • Over the past 3 years, Abivax's Shares Outstanding (Weighted Average) (Yearly) stood at $42.5 million in 2022, then surged by 47.77% to $62.9 million in 2023, then climbed by 0.10% to $62.9 million in 2024.